Walleye Capital LLC Pacira Bio Sciences, Inc. Transaction History

Walleye Capital LLC

$38.9 Billion
Q4 2024

A detailed history of Walleye Capital LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 6,500 shares of PCRX stock, worth $169,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,500

Holding current value

$169,260

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$15.3 - $20.33 $731,997 - $972,648	47,843 New	47,843 $901,000
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $177,390 - $227,213	-6,404 Reduced 74.61%	2,179 $63,000
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $225,904 - $294,482	8,583 New	8,583 $289,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $50,945 - $76,638	1,334 Added 1.24%	109,171 $4.22 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $3.57 Million - $4.1 Million	69,678 Added 182.6%	107,837 $5.74 Million
Q2 2022 Aug 08, 2022	SELL	$51.49 - $81.64 $4.99 Million - $7.91 Million	-96,868 Reduced 71.74%	38,159 $2.23 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $1.2 Million - $1.52 Million	19,930 Added 17.32%	135,027 $10.3 Million
Q4 2021 Mar 03, 2022	BUY	$47.97 - $62.21 $1.17 Million - $1.51 Million	24,315 Added 26.78%	115,097 $6.93 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $198,671 - $222,886	-3,636 Reduced 3.85%	90,782 $5.08 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $3.2 Million - $3.78 Million	54,056 Added 133.93%	94,418 $5.73 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $259,777 - $345,231	-4,380 Reduced 9.79%	40,362 $2.83 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $2.26 Million - $2.96 Million	44,742 New	44,742 $2.68 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $162,624 - $277,041	-5,280 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $144,272 - $257,556	5,080 Added 2540.0%	5,280 $177,000
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $7,262 - $9,366	200 New	200 $9,000
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $91,860 - $115,894	-2,576 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $94,204 - $123,570	2,576 New	2,576 $112,000

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.19B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Pacira Bio Sciences, Inc. Transaction History